Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 3
1980 8
1981 4
1982 5
1983 8
1984 7
1985 7
1986 5
1987 21
1988 21
1989 31
1990 40
1991 23
1992 14
1993 18
1994 14
1995 11
1996 12
1997 10
1998 9
1999 3
2000 4
2001 8
2002 6
2003 2
2004 3
2005 5
2006 1
2007 4
2008 4
2010 2
2011 1
2012 1
2013 2
2015 1
2018 3
2019 3
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

326 results
Results by year
Filters applied: . Clear all
Page 1
Transplantation of the lungs.
Smyth RL, Higenbottam TW, Scott JP, Wallwork J. Smyth RL, et al. Among authors: higenbottam tw. Respir Med. 1989 Nov;83(6):459-66. doi: 10.1016/s0954-6111(89)80126-x. Respir Med. 1989. PMID: 2695987 Review.
U-BIOPRED: evaluation of the value of a public-private partnership to industry.
Riley JH, Erpenbeck VJ, Matthews JG, Holweg CTJ, Compton C, Seibold W, Higenbottam T, Wagers S, Rowe A, Myles D; Industry Representatives of the U-BIOPRED Study Group. Riley JH, et al. Among authors: higenbottam t. Drug Discov Today. 2018 Sep;23(9):1622-1634. doi: 10.1016/j.drudis.2018.06.015. Epub 2018 Jun 21. Drug Discov Today. 2018. PMID: 29936248 Review.
Lung lipids and disease.
Higenbottam T. Higenbottam T. Respiration. 1989;55 Suppl 1:14-27. doi: 10.1159/000195747. Respiration. 1989. PMID: 2682865 Review.
Heart-lung-liver transplantation.
Dennis CM, McNeil KD, Dunning J, Stewart S, Friend PJ, Alexander G, Higenbottam TW, Calne RY, Wallwork J. Dennis CM, et al. Among authors: higenbottam tw. J Heart Lung Transplant. 1996 May;15(5):536-8. J Heart Lung Transplant. 1996. PMID: 8771510
Primary pulmonary hypertension.
Higenbottam T. Higenbottam T. Br Med J (Clin Res Ed). 1986 Dec 6;293(6560):1456-7. doi: 10.1136/bmj.293.6560.1456. Br Med J (Clin Res Ed). 1986. PMID: 3099910 Free PMC article. No abstract available.
Treatments for severe pulmonary hypertension.
Higenbottam T, Stenmark K, Simonneau G. Higenbottam T, et al. Lancet. 1999 Jan 30;353(9150):338-40. doi: 10.1016/S0140-6736(98)00330-4. Lancet. 1999. PMID: 9950432 Review. No abstract available.
Adverse reactions and interactions of cyclosporin.
Scott JP, Higenbottam TW. Scott JP, et al. Among authors: higenbottam tw. Med Toxicol Adverse Drug Exp. 1988 Mar-Apr;3(2):107-27. doi: 10.1007/BF03259936. Med Toxicol Adverse Drug Exp. 1988. PMID: 3287088 Review.
Pulmonary hypertension as a result of drug therapy.
Higenbottam T, Laude L, Emery C, Essener M. Higenbottam T, et al. Clin Chest Med. 2004 Mar;25(1):123-31. doi: 10.1016/S0272-5231(03)00133-3. Clin Chest Med. 2004. PMID: 15062604 Review.
Non-prostanoid endothelium-derived vasoactive factors.
Dinh Xuan AT, Higenbottam TW. Dinh Xuan AT, et al. Among authors: higenbottam tw. J Int Med Res. 1989 Jul-Aug;17(4):305-15. doi: 10.1177/030006058901700401. J Int Med Res. 1989. PMID: 2676646 Free article. Review.
326 results